Prelude Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRLD and other ETFs, options, and stocks.

About PRLD

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. 

CEO
Krishna Vaddi
CEOKrishna Vaddi
Employees
131
Employees131
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
2016
Founded2016
Employees
131
Employees131

PRLD Key Statistics

Market cap
45.08M
Market cap45.08M
Price-Earnings ratio
-0.44
Price-Earnings ratio-0.44
Dividend yield
—
Dividend yield—
Average volume
287.96K
Average volume287.96K
High today
$0.838
High today$0.838
Low today
$0.78
Low today$0.78
Open price
$0.7851
Open price$0.7851
Volume
97.28K
Volume97.28K
52 Week high
$6.80
52 Week high$6.80
52 Week low
$0.6101
52 Week low$0.6101

People also own

Based on the portfolios of people who own PRLD. This list is generated using Robinhood data, and it’s not a recommendation.
Lucid Group
Workhorse
Plug Power
Virgin Galactic Holdings
Tilray Brands
FuelCell Energy
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.